TR201713929A2 - Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari - Google Patents

Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari Download PDF

Info

Publication number
TR201713929A2
TR201713929A2 TR2017/13929A TR201713929A TR201713929A2 TR 201713929 A2 TR201713929 A2 TR 201713929A2 TR 2017/13929 A TR2017/13929 A TR 2017/13929A TR 201713929 A TR201713929 A TR 201713929A TR 201713929 A2 TR201713929 A2 TR 201713929A2
Authority
TR
Turkey
Prior art keywords
chitosan
alginate
hemostatic compositions
compositions
hemostatic
Prior art date
Application number
TR2017/13929A
Other languages
English (en)
Inventor
Güner Di̇cle
Palantöken Arzu
Türkyilmaz Ali̇
Kenar Özlem
Original Assignee
Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montero Gida Sanayi Ve Ticaret Anonim Sirketi filed Critical Montero Gida Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/13929A priority Critical patent/TR201713929A2/tr
Priority to PCT/TR2018/050506 priority patent/WO2019059867A1/en
Publication of TR201713929A2 publication Critical patent/TR201713929A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Bu buluş, kitosan veya onun farmasötik olarak kabul edilebilir tuzları ve aljinat içeren granül formunda farmasötik hemostatik kompozisyonlarla ilgilidir.
TR2017/13929A 2017-09-20 2017-09-20 Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari TR201713929A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/13929A TR201713929A2 (tr) 2017-09-20 2017-09-20 Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
PCT/TR2018/050506 WO2019059867A1 (en) 2017-09-20 2018-09-19 HEMOSTATIC COMPOSITIONS OF CHITOSAN AND ALGINATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/13929A TR201713929A2 (tr) 2017-09-20 2017-09-20 Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari

Publications (1)

Publication Number Publication Date
TR201713929A2 true TR201713929A2 (tr) 2019-04-22

Family

ID=65237118

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/13929A TR201713929A2 (tr) 2017-09-20 2017-09-20 Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari

Country Status (2)

Country Link
TR (1) TR201713929A2 (tr)
WO (1) WO2019059867A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111729126B (zh) * 2020-07-10 2022-04-05 北京红立方医疗设备有限公司 一种基于壳聚糖和组织因子组合的止血材料及其制备方法
US11903961B2 (en) * 2020-08-18 2024-02-20 Amrita Vishwa Vidyapeetham Hemostatic agent and method of production thereof
CN115531596A (zh) * 2021-06-30 2022-12-30 苏州美创医疗科技有限公司 止血凝胶组合物及其制备方法
CN113521379A (zh) * 2021-07-12 2021-10-22 重庆大清海德生物技术有限公司 一种大创伤壳聚糖止血颗粒的制备方法
CN114984304B (zh) * 2022-07-13 2023-07-18 温州市安多多医疗器械有限公司 一种抗菌止血凝胶粉及其制备方法
CN115779136B (zh) * 2022-12-15 2024-04-12 湖南中腾湘岳生物科技有限公司 一种医用止血材料及其制备方法
KR102743315B1 (ko) * 2024-06-25 2024-12-16 주식회사 이노파마 카올린과 셀룰로오스를 혼합한 분사형 지혈제 제조방법 및 그에 따라 제조된 분사형 지혈제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5836970A (en) 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
JP2009505685A (ja) 2005-07-13 2009-02-12 ヘムコン， インコーポレイテッド キトサンのような親水性ポリマーフォームから形成された粒状止血薬を使用する、止血の組成、アセンブリ、システムおよび方法
GB0526505D0 (en) 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
GB201104175D0 (en) 2011-03-11 2011-04-27 Medtrade Products Ltd Haemostatic material
CN104311253B (zh) * 2014-09-29 2017-07-04 四川天农农资有限公司 一种壳聚糖缓释肥料微球及其制备方法
GB201501330D0 (en) 2015-01-27 2015-03-11 Medtrade Products Ltd Composition for a wound dressing
CN107921172A (zh) 2015-04-27 2018-04-17 马克西姆·卡尔波夫 止血组合物及装置
CN106822987B (zh) * 2017-04-07 2019-05-21 广东海洋大学 一种壳聚糖-海藻酸盐多孔球珠止血材料的制备方法
CN107029280B (zh) * 2017-04-07 2019-04-19 广东海洋大学 一种壳聚糖-海藻酸盐软胶囊粒止血材料的制备方法

Also Published As

Publication number Publication date
WO2019059867A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
IL279036A (en) Pharmaceutical combination, the composition and preparation of a combination containing an activator of glucokinase and an inhibitor of SGLT-2, preparation methods and their uses
MX2020001555A (es) Preparaciones terapéuticas de glicanos y métodos relacionados con estas.
CA2956871C (en) Compounds active towards bromodomains
WO2017095944A8 (en) Methods and compositions relating to chondrisomes from blood products
PH12018500586B1 (en) Farnesoid x receptor agonists and uses thereof
PH12019501199A1 (en) Calcium lactate compositions and methods of use
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
EP3412292B8 (en) Use of methoxatin, derivative and/or salt thereof in sjogren's syndrome and pharmaceutical composition
IN2013MU03583A (tr)
MX2017000041A (es) Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
EP4218736A3 (en) Compositions comprising 15-hepe
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2016001422A (es) Composicion farmaceutica de fingolimod.
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.
MX2018000092A (es) Nuevo lipolantipeptido biciclico, preparacion y uso como agente antimicrobiano.
IL273988A (en) Compounds of cannabidiol and chitosan, and methods for their use
PH12016501548B1 (en) Cholesteryl ester transfer protein (cetp) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12018501758A1 (en) Oritavancin formulations
WO2016197042A8 (en) Modified or targeted release formulations of linaclotide
WO2020022975A3 (en) New pharmaceutical compositions in the treatment of copd
EP3881845A3 (en) Combination of trazodone and gabapentin for the treatment of pain
UA101726U (xx) Лікарський препарат гемостатичної дії
HK40020689A (en) Pharmaceutical compositions and uses thereof